from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1065/-

LFCtreatmentdescriptionclass of inhibitor

-0.123

Amikacinug/mL Amikacintranslation

-0.536

Cap5-10ug/mL Capreomycintranslation

-0.884

Rox10-50 ug/mL Roxithromycintranslation

-0.158

SM2-5 ug/mL Streptomycintranslation

-0.569

Tet5-10 ug/mL Tetracyclinetranslation

0.519

Rif0.2-5ug/mL Rifampicintranscription

0.975

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.941

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.614

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.068

CPZ10-50 ug/mL Chlorpromazinerespiration

0.221

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.189

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.957

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.226

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.585

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.435

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.231

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.098

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.119

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.336

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.613

KCN5-20 ug/mL Potassium cyaniderespiration

-0.084

NaN30.2-2 mM Sodium aziderespiration

-0.302

Nigericin50 uM Nigericinrespiration

0.751

TRC10-150 ug/mL Triclosanrespiration

0.885

TRZ10-25 ug/mL Thioridazinerespiration

-0.491

Valinomycin0.5-10 uM Valinomycinrespiration

-1.697

ZnSO42 mM ZnSO4respiration

-0.001

menadione6-10 ug/mL Menadionerespiration

-0.053

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.557

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.176

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.900

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.912

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

-0.228

Cephalexin20-100 ug/mL CephalexincellWall

-0.458

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.533

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.382

EMB10-20 ug/mL EthambutolcellWall

-0.656

Eta12-40 ug/mL EthionamidecellWall

-0.655

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.187

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.047

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.729

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.037

BZA0.12 mg/mL BenzamidearomaticAmides

-0.993

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.111

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.117

H2O24 mM hydrogen peroxideDNAdamaging

-0.521

Levo10 ug/mL LevofloxacinDNAdamaging

-0.021

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.152

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.015

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.552

UVUV-irradiationDNAdamaging

1.937

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.084

Antimycin12.5-50 ug/mL Antimycin A?

-0.659

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.142

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.477

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.085

PA8240.2-2 ug/mL PA-824?

1.630

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.205

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.396

Verapamil50 uM Verapamil?

0.126

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.414

methoxatin10-20 ug/mL Methoxatin?